Brooklyn Investment Group

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1795705 NEW YORK, NY

Position in VRTX

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$2,788,642

+$866,849 QoQ

Shares Held

6,245

+47.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brooklyn Investment Group holds $23,138,608 across 42 Biotechnology names. VRTX ranks #1 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,245	$2,788,642
2	REGN	Regeneron Pharmaceuticals, Inc.	1,889	$1,459,516
3	ROIV	Roivant Sciences Ltd.	50,312	$1,393,642
4	ARGX	Argenx SE	1,697	$1,239,234
5	MRNA	Moderna, Inc.	23,110	$1,173,988
6	GMAB	Genmab A/S	35,823	$961,131
7	ASND	Ascendis Pharma A/S	4,072	$931,388
8	RVMD	Revolution Medicines, Inc.	8,994	$874,666

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,788,642	6,245	+47.3%	Shares	Defined	2026-04-29
2025-12-31	$1,921,793	4,239	+52.6%	Shares	Defined	2026-02-12
2025-09-30	$1,087,584	2,777	-2.5%	Shares	Defined	2025-11-14
2025-06-30	$1,267,484	2,847	+6.2%	Shares	Defined	2025-08-14
2025-03-31	$1,299,317	2,680	+40.6%	Shares	Defined	2025-05-13
2024-12-31	$767,546	1,906	+1.8%	Shares	Defined	2025-01-15
2024-09-30	$871,094	1,873	+4.9%	Shares	Defined	2024-11-13
2024-06-30	$837,133	1,786	0.0%	Shares	Defined	2024-08-12
2024-03-31	$746,565	1,786	-0.5%	Shares	Defined	2024-05-07
2023-12-31	$730,367	1,795	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.